Alzheimer's disease drug development pipeline: 2023
Jeffrey L. Cummings(University of Nevada, Las Vegas), Feixiong Cheng(Cleveland Clinic)
Alzheimer s & Dementia Translational Research & Clinical Interventions
April 1, 2023
Cited by 457
Related Papers
Designing the next-generation clinical care pathway for Alzheimer’s disease
|Nature Aging|2022|193
Burden of Illness in People with Alzheimer's Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality
|The Journal of Prevention of Alzheimer s Disease|2023|139
Alzheimer’s Disease: Combination Therapies and Clinical Trials for Combination Therapy Development
|CNS Drugs|2024|47